Cargando…

Prognostic value of the Glasgow prognostic score in colorectal cancer: a meta-analysis of 9,839 patients

PURPOSE: The aim of this study was to perform a systematic review and meta-analysis to evaluate the value of the Glasgow prognostic score (GPS) or modified Glasgow prognostic score (mGPS) in patients with colorectal cancer (CRC). METHODS: A comprehensive medical literature search was performed using...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Xin, Guo, Wanying, Xu, Wei, Zhang, Xuelei, Shi, Zhijie, Zheng, Leizhen, Zhao, Wenzhao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307678/ https://www.ncbi.nlm.nih.gov/pubmed/30636896 http://dx.doi.org/10.2147/CMAR.S185350

Ejemplares similares

The prognostic value of modified Glasgow Prognostic Score in pancreatic cancer: a meta-analysis
por: Zhang, Huan, et al.
Publicado: (2020)

The prognostic value of pretreatment Glasgow Prognostic Score in patients with esophageal cancer: a meta-analysis
por: Wang, Yan, et al.
Publicado: (2019)

Workshop 83_9: Setup & Globals
Publicado: (1983)

Glasgow Prognostic Score and modified Glasgow Prognostic Score and survival in patients with hepatocellular carcinoma: a meta-analysis
por: Lu, Lingling, et al.
Publicado: (2021)

Inflammation-based score (Glasgow prognostic score) as an independent prognostic factor in colorectal cancer patients
por: Choi, Kyeong Woon, et al.
Publicado: (2014)

Prognostic Value of C-Reactive Protein, Glasgow Prognostic Score, and C-Reactive Protein-to-Albumin Ratio in Colorectal Cancer
por: Zhou, Jiahui, et al.
Publicado: (2021)

Prognostic value of pretreatment modified Glasgow Prognostic Score in small cell lung cancer: A meta-analysis
por: Xie, Yulian, et al.
Publicado: (2023)

A Meta-Analysis of Glasgow Prognostic Score and Modified Glasgow Prognostic Score as Biomarkers for Predicting Survival Outcome in Renal Cell Carcinoma
por: Tong, Tongyu, et al.
Publicado: (2020)

Prognostic Value of Glasgow Prognostic Score in Non-small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Zhang, Chuan-Long, et al.
Publicado: (2022)

Prognostic role of Glasgow prognostic score in patients with colorectal cancer: evidence from population studies
por: Liu, Yangyang, et al.
Publicado: (2017)

Validation of the conventional Glasgow Prognostic Score and development of the improved Glasgow Prognostic Score in patients with stage 0‐III colorectal cancer after curative resection
por: Ishikawa, Satoshi, et al.
Publicado: (2021)

Prognostic Value of the Modified Glasgow Prognostic Score in Patients Undergoing Radical Surgery for Hepatocellular Carcinoma
por: Ni, Xiao-Chun, et al.
Publicado: (2015)

Glasgow prognostic score is a better predictor of the long-term survival in patients with gastric cancer, compared to the modified Glasgow prognostic score or high-sensitivity modified Glasgow prognostic score
por: Hirahara, Noriyuki, et al.
Publicado: (2020)

The high-sensitivity modified Glasgow prognostic score is superior to the modified Glasgow prognostic score as a prognostic predictor for head and neck cancer
por: Hanai, Nobuhiro, et al.
Publicado: (2018)

Prognostic value of neutrophil/lymphocyte, platelet/lymphocyte, lymphocyte/monocyte ratios and Glasgow prognostic score in osteosarcoma: A meta-analysis
por: Peng, Li-Peng, et al.
Publicado: (2022)

Prognostic value of preoperative modified Glasgow prognostic score in surgical non-small cell lung cancer: A meta-analysis
por: Yang, Chenli, et al.
Publicado: (2023)

Prognostic Role of Glasgow Prognostic Score in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Li, Mu-xing, et al.
Publicado: (2015)

Prognostic Significance of the Modified Glasgow Prognostic Score in Patients With Pancreatic Cancer: A Meta-Analysis
por: Fu, Wen, et al.
Publicado: (2020)

Prognostic Value of the Glasgow Prognostic Score on Overall Survival in patients with Advanced Non-Small Cell Lung Cancer
por: Pan, Mingmei, et al.
Publicado: (2021)

Prognostic and clinical significance of modified glasgow prognostic score in pancreatic cancer: a meta-analysis of 4,629 patients
por: Wu, Dongdong, et al.
Publicado: (2021)

The preoperative sensitive-modified Glasgow prognostic score is superior to the modified Glasgow prognostic score in predicting long-term survival for esophageal squamous cell carcinoma
por: Tian, Rui, et al.
Publicado: (2016)

The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma
por: Kinoshita, Akiyoshi, et al.
Publicado: (2013)

Prognostic Value of Post First-Line Chemotherapy Glasgow Prognostic Score in Advanced Non-Small Cell Lung Cancer
por: Stokke, Kristin, et al.
Publicado: (2022)

Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer
por: Jiang, X, et al.
Publicado: (2012)

The Modified Glasgow Prognostic Score as a Predictor of Survival After Hepatectomy for Colorectal Liver Metastases
por: Nakagawa, Kazuya, et al.
Publicado: (2014)

Sarcopenia and Myosteatosis Are Associated with Neutrophil to Lymphocyte Ratio but Not Glasgow Prognostic Score in Colorectal Cancer Patients
por: Aro, Raila, et al.
Publicado: (2022)

Biliary drainage improves the predictive value of modified Glasgow Prognostic Scores in inoperable pancreatic cancer
por: Iino, Chikara, et al.
Publicado: (2017)

Prognostic Value of High-Sensitivity Modified Glasgow Prognostic Score in Castration-Resistant Prostate Cancer Patients Who Received Docetaxel
por: Ando, Keisuke, et al.
Publicado: (2021)

Prognostic value of preoperative high-sensitivity modified Glasgow prognostic score in advanced colon cancer: a retrospective observational study
por: Kasahara, Kenta, et al.
Publicado: (2022)

Prognostic value of immune scores in the microenvironment of colorectal cancer
por: Yuan, Wenliang, et al.
Publicado: (2020)

Clinical utility of the modified Glasgow prognostic score in lung cancer: A meta-analysis
por: Jin, Jing, et al.
Publicado: (2017)

Modified Glasgow Prognostic Score is Better for Predicting Oncological Outcome in Patients with Soft Tissue Sarcoma, Compared to High-Sensitivity Modified Glasgow Prognostic Score
por: Nakamura, Tomoki, et al.
Publicado: (2022)

Modified Glasgow prognostic score as a prognostic factor for renal cell carcinomas: a systematic review and meta-analysis
por: Hu, Xu, et al.
Publicado: (2019)

External validation of the modified Glasgow prognostic score for renal cancer
por: Tai, Caroline G., et al.
Publicado: (2014)

Glasgow Prognostic Score as a Marker of Mortality after TAVI
por: Abacioglu, Ozge Ozcan, et al.
Publicado: (2021)

Clinical Implication of Inflammation-Based Prognostic Score in Pancreatic Cancer: Glasgow Prognostic Score Is the Most Reliable Parameter
por: Yamada, Suguru, et al.
Publicado: (2016)

Glasgow prognostic score and combined positive score for locally advanced rectal cancer
por: Feng, Yanru, et al.
Publicado: (2022)

Glasgow PrognosticScore as a Predictor of BevacizumabEfficacy in the First-line Treatment with Metastatic Colorectal Cancer
por: Huang, Yuanyuan, et al.
Publicado: (2019)

The Prognostic Role of Glasgow Prognostic Score and C-reactive Protein to Albumin Ratio for Sarcoma: A System Review and Meta-Analysis
por: Fang, Erhu, et al.
Publicado: (2020)

Prognostic Significance of Glasgow Prognostic Score in Patients Undergoing Esophagectomy for Esophageal Squamous Cell Carcinoma
por: Feng, Ji-Feng, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_uf0ed0j0aa3aovh2vdurmt9mht